DDX53 and neoplasm: In the CT26 model we observed a shift in the phenotype of the tumour-infiltrating myeloid cells upon anti-CD27 treatment, with CD11b+ cells gaining F4/80 expression, indicative of macrophage differentiation36 (Fig. 1g, h and Supplementary Fig. 1b).